| __timestamp | Intra-Cellular Therapies, Inc. | Pharming Group N.V. |
|---|---|---|
| Wednesday, January 1, 2014 | 10337679 | 4042025 |
| Thursday, January 1, 2015 | 18187286 | 5279557 |
| Friday, January 1, 2016 | 24758063 | 8073913 |
| Sunday, January 1, 2017 | 23666957 | 44864073 |
| Monday, January 1, 2018 | 30099855 | 53488904 |
| Tuesday, January 1, 2019 | 64947625 | 65896361 |
| Wednesday, January 1, 2020 | 186363444 | 69968267 |
| Friday, January 1, 2021 | 272611040 | 92047281 |
| Saturday, January 1, 2022 | 358782000 | 131819000 |
| Sunday, January 1, 2023 | 409864000 | 87501000 |
Unleashing the power of data
In the competitive world of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for profitability. From 2014 to 2023, Intra-Cellular Therapies, Inc. and Pharming Group N.V. have shown distinct strategies in handling these costs. Intra-Cellular Therapies, Inc. saw a staggering increase in SG&A expenses, peaking at approximately $410 million in 2023, a nearly 40-fold rise from 2014. In contrast, Pharming Group N.V. maintained a more stable trajectory, with expenses reaching around $88 million in 2023, a modest 21-fold increase from 2014. This data suggests that while Intra-Cellular Therapies, Inc. has aggressively expanded its operations, Pharming Group N.V. has opted for a more conservative approach. Understanding these trends can provide valuable insights for investors and stakeholders looking to gauge the financial health and strategic direction of these companies.
Breaking Down SG&A Expenses: Johnson & Johnson vs Intra-Cellular Therapies, Inc.
SG&A Efficiency Analysis: Comparing AbbVie Inc. and Pharming Group N.V.
SG&A Efficiency Analysis: Comparing Novartis AG and Intra-Cellular Therapies, Inc.
Comparing SG&A Expenses: Regeneron Pharmaceuticals, Inc. vs Intra-Cellular Therapies, Inc. Trends and Insights
Selling, General, and Administrative Costs: Teva Pharmaceutical Industries Limited vs Intra-Cellular Therapies, Inc.
Genmab A/S and Pharming Group N.V.: SG&A Spending Patterns Compared
Intra-Cellular Therapies, Inc. and Dr. Reddy's Laboratories Limited: SG&A Spending Patterns Compared
Operational Costs Compared: SG&A Analysis of Intra-Cellular Therapies, Inc. and Catalent, Inc.
Who Optimizes SG&A Costs Better? Intra-Cellular Therapies, Inc. or Corcept Therapeutics Incorporated
Intra-Cellular Therapies, Inc. vs Ionis Pharmaceuticals, Inc.: SG&A Expense Trends
Intra-Cellular Therapies, Inc. or Amphastar Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Operational Costs Compared: SG&A Analysis of Pharming Group N.V. and Amneal Pharmaceuticals, Inc.